中华内分泌外科杂志
中華內分泌外科雜誌
중화내분비외과잡지
CHINESE JOURNAL OF ENDOCRINE SURGERY
2011年
2期
76-79
,共4页
柳迎昭%俞力%龚丹丹%周永静%武正炎%蒋鹏程%范钰
柳迎昭%俞力%龔丹丹%週永靜%武正炎%蔣鵬程%範鈺
류영소%유력%공단단%주영정%무정염%장붕정%범옥
甲状腺肿瘤%PLK1%小干扰RNA%增殖%凋亡
甲狀腺腫瘤%PLK1%小榦擾RNA%增殖%凋亡
갑상선종류%PLK1%소간우RNA%증식%조망
Thyroid carcinoma%Polo-like kinase-1%Small interfering RNA%Proliferation%Apoptosis
目的 构建保罗样激酶-1(PLK1)基因小干扰RNA(siRNA),并观察其对甲状腺癌细胞增殖和凋亡的影响.方法 设计合成5个PLK1 siRNA(S1、S2、S3、S4、S5),转染人甲状腺癌ARO细胞后,采用实时定量RT-PCR方法筛选下调PLK1 mRNA效果最好的siRNA;然后以该siRNA转染ARO细胞后,分别以实时定量RT-PCR和Western blot检测各组细胞PLK1基因表达情况;以MTT法检测对各组细胞增殖的影响;分别以caspase-3活性和TUNEL方法明确甲状腺癌细胞凋亡情况.结果 5个siRNA均明显下调PLK1 mRNA水平,以S4效果最好,抑制率达91.5%.MTr结果显示,S4 siRNA转染对甲状腺癌细胞增殖均有明显的抑制作用,且呈浓度和时间依赖性(P<0.05).与对照组比较,S4 siRNA转染组癌细胞caspase-3活性明显升高,且呈浓度和时间依赖性(r=0.919;r=0.957);TUNEL结果显示,S4 siRNA转染组出现明显的凋亡现象,且呈浓度依赖性(r=0.932).结论 PLK1基因在甲状腺未分化癌细胞增殖中具有重要的调控作用.PLK1 siRNA转染可明显抑制癌细胞增殖,诱导凋亡是其重要机制之一.
目的 構建保囉樣激酶-1(PLK1)基因小榦擾RNA(siRNA),併觀察其對甲狀腺癌細胞增殖和凋亡的影響.方法 設計閤成5箇PLK1 siRNA(S1、S2、S3、S4、S5),轉染人甲狀腺癌ARO細胞後,採用實時定量RT-PCR方法篩選下調PLK1 mRNA效果最好的siRNA;然後以該siRNA轉染ARO細胞後,分彆以實時定量RT-PCR和Western blot檢測各組細胞PLK1基因錶達情況;以MTT法檢測對各組細胞增殖的影響;分彆以caspase-3活性和TUNEL方法明確甲狀腺癌細胞凋亡情況.結果 5箇siRNA均明顯下調PLK1 mRNA水平,以S4效果最好,抑製率達91.5%.MTr結果顯示,S4 siRNA轉染對甲狀腺癌細胞增殖均有明顯的抑製作用,且呈濃度和時間依賴性(P<0.05).與對照組比較,S4 siRNA轉染組癌細胞caspase-3活性明顯升高,且呈濃度和時間依賴性(r=0.919;r=0.957);TUNEL結果顯示,S4 siRNA轉染組齣現明顯的凋亡現象,且呈濃度依賴性(r=0.932).結論 PLK1基因在甲狀腺未分化癌細胞增殖中具有重要的調控作用.PLK1 siRNA轉染可明顯抑製癌細胞增殖,誘導凋亡是其重要機製之一.
목적 구건보라양격매-1(PLK1)기인소간우RNA(siRNA),병관찰기대갑상선암세포증식화조망적영향.방법 설계합성5개PLK1 siRNA(S1、S2、S3、S4、S5),전염인갑상선암ARO세포후,채용실시정량RT-PCR방법사선하조PLK1 mRNA효과최호적siRNA;연후이해siRNA전염ARO세포후,분별이실시정량RT-PCR화Western blot검측각조세포PLK1기인표체정황;이MTT법검측대각조세포증식적영향;분별이caspase-3활성화TUNEL방법명학갑상선암세포조망정황.결과 5개siRNA균명현하조PLK1 mRNA수평,이S4효과최호,억제솔체91.5%.MTr결과현시,S4 siRNA전염대갑상선암세포증식균유명현적억제작용,차정농도화시간의뢰성(P<0.05).여대조조비교,S4 siRNA전염조암세포caspase-3활성명현승고,차정농도화시간의뢰성(r=0.919;r=0.957);TUNEL결과현시,S4 siRNA전염조출현명현적조망현상,차정농도의뢰성(r=0.932).결론 PLK1기인재갑상선미분화암세포증식중구유중요적조공작용.PLK1 siRNA전염가명현억제암세포증식,유도조망시기중요궤제지일.
Objective To study effects of polo-like kinase-1(PLK1)small interfering RNA(siRNA)on proliferation and apoptosis of undifferentiated human thyroid cancer cells.Methods 5 PLK1 siRNA(S1,S2,S3,S4 and S5)were constructed and used to transfect human thyroid cancer cell line ARO.RT-PCR was employed to pick out the most effective siRNA,which was then used to transfect ARO cell.RT-PCR and western blot were used to detect PLK1 expression in thyroid cancer cells,which were divided into different groups.MTT assay was performed to examine the effects of PLK1 siRNA on thyroid cancer cells in all groups.Apoptosis of thyroid cancer cells was observed by caspase-3 activity and TUNEL.Results All the 5 siRNA down-regulated PLK1 mRNA expression.among which S4 showed the best effect.S4 transfection could obviously inhibit proliferation of thyroid cancer cells in dose and time dependent manner.Compared with control groups,caspase-3 activity of cancer cells in s4 transfeeted group increased significantly.The effect of S4 transfection was dose and time dependent.TUNEL results showed apoptosis of cancer cells transfected by S4 siRNA was obvious and apoptosis of cells was dose-dependent.Conclusions PLK1 may play an important role in proliferation of undifferentiated thyroid carcinoma.PLK1 siRNA transfection can inhibit proliferation of throid cancer cell through apoptosis induction.